Screener
Arcus Biosciences RCUS Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's retained earnings?
- Arcus Biosciences (RCUS) reported retained earnings of -$1.7B in Q2 2026.
- How has Arcus Biosciences's retained earnings changed year-over-year?
- Arcus Biosciences's retained earnings decreased by 37.0% year-over-year, from -$1.24B to -$1.7B.
- What is the long-term trend for Arcus Biosciences's retained earnings?
- Over 5 years (2020 to 2025), Arcus Biosciences's retained earnings has grown at a 35.2% compound annual growth rate (CAGR), from -$328.18M to -$1.49B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Arcus Biosciences's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude